Protein may hold promise for diabetes treatment

03/29/2012 | Yahoo!

Researchers at the Gladstone Institutes found that mice genetically engineered to lack a protein called p75 neurotrophin receptor had better insulin response when fed with a normal diet. The mice also showed higher glucose absorption in response to insulin compared with normal mice when the action of the p75NTR protein was blocked in fat cells. "Therapies targeted at p75NTR may represent a new therapeutic approach for diabetes," researcher Katerina Akassoglou reported in the Proceedings of the National Academy of Sciences.

View Full Article in:

Yahoo!

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Catheter Engineer Manager
ASAHI INTECC, Orange County CA R&D Center
Santa Ana, CA
Neurovascular Intervention Product Sales Rep, North East
ASAHI INTECC
Multiple Locations, SL_Multiple Locations
Senior Manager, Compliance
Stryker
Fremont, CA
Director, Office of Device Evaluation
FDA, Center for Devices and Radiological Health
Silver Spring, MD
Director, Office of Compliance
FDA, Center for Devices and Radiological Health
Silver Spring, MD